sri 63072 has been researched along with Hypersensitivity, Type III in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andres, G; Brentjens, J; Camussi, G; Pawlowski, I; Saunders, R | 1 |
1 other study(ies) available for sri 63072 and Hypersensitivity, Type III
| Article | Year |
|---|---|
Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin.
Topics: Animals; Arthus Reaction; Complement System Proteins; Female; Fluorescent Antibody Technique; Glomerulonephritis; Histocytochemistry; Immune Complex Diseases; Immunoglobulin G; Platelet Activating Factor; Rats; Rats, Inbred Lew; Thiazoles | 1987 |